BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12446687)

  • 1. Identification of a promoter-specific transcriptional activation domain at the C terminus of the Wnt effector protein T-cell factor 4.
    Hecht A; Stemmler MP
    J Biol Chem; 2003 Feb; 278(6):3776-85. PubMed ID: 12446687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways.
    Labbé E; Letamendia A; Attisano L
    Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8358-63. PubMed ID: 10890911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylation of human TCF4 (TCF7L2) proteins attenuates inhibition by the HBP1 repressor and induces a conformational change in the TCF4::DNA complex.
    Elfert S; Weise A; Bruser K; Biniossek ML; Jägle S; Senghaas N; Hecht A
    PLoS One; 2013; 8(4):e61867. PubMed ID: 23613959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new beta-catenin-dependent activation domain in T cell factor.
    Atcha FA; Munguia JE; Li TW; Hovanes K; Waterman ML
    J Biol Chem; 2003 May; 278(18):16169-75. PubMed ID: 12582159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt/(beta)-catenin signaling regulates the expression of the homeobox gene Cdx1 in embryonic intestine.
    Lickert H; Domon C; Huls G; Wehrle C; Duluc I; Clevers H; Meyer BI; Freund JN; Kemler R
    Development; 2000 Sep; 127(17):3805-13. PubMed ID: 10934025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of TCF4 expression as a transcriptional target of beta-catenin/p300 complexes during trans-differentiation of endometrial carcinoma cells.
    Saegusa M; Hashimura M; Kuwata T; Hamano M; Okayasu I
    Lab Invest; 2005 Jun; 85(6):768-79. PubMed ID: 15806138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell factor 4N (TCF-4N), a novel isoform of mouse TCF-4, synergizes with beta-catenin to coactivate C/EBPalpha and steroidogenic factor 1 transcription factors.
    Kennell JA; O'Leary EE; Gummow BM; Hammer GD; MacDougald OA
    Mol Cell Biol; 2003 Aug; 23(15):5366-75. PubMed ID: 12861022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromatin-specific regulation of LEF-1-beta-catenin transcription activation and inhibition in vitro.
    Tutter AV; Fryer CJ; Jones KA
    Genes Dev; 2001 Dec; 15(24):3342-54. PubMed ID: 11751639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A beta-catenin/XTcf-3 complex binds to the siamois promoter to regulate dorsal axis specification in Xenopus.
    Brannon M; Gomperts M; Sumoy L; Moon RT; Kimelman D
    Genes Dev; 1997 Sep; 11(18):2359-70. PubMed ID: 9308964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of beta -catenin transformation by the p300 transcriptional coactivator.
    Sun Y; Kolligs FT; Hottiger MO; Mosavin R; Fearon ER; Nabel GJ
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12613-8. PubMed ID: 11050151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A direct beta-catenin-independent interaction between androgen receptor and T cell factor 4.
    Amir AL; Barua M; McKnight NC; Cheng S; Yuan X; Balk SP
    J Biol Chem; 2003 Aug; 278(33):30828-34. PubMed ID: 12799378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smad4 and beta-catenin co-activators functionally interact with lymphoid-enhancing factor to regulate graded expression of Msx2.
    Hussein SM; Duff EK; Sirard C
    J Biol Chem; 2003 Dec; 278(49):48805-14. PubMed ID: 14551209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphoid enhancer factor-1 and beta-catenin inhibit Runx2-dependent transcriptional activation of the osteocalcin promoter.
    Kahler RA; Westendorf JJ
    J Biol Chem; 2003 Apr; 278(14):11937-44. PubMed ID: 12551949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cohesin SMC3 is a target the for beta-catenin/TCF4 transactivation pathway.
    Ghiselli G; Coffee N; Munnery CE; Koratkar R; Siracusa LD
    J Biol Chem; 2003 May; 278(22):20259-67. PubMed ID: 12651860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of Cdx1 by oncogenic beta-catenin/Tcf4 in colon cancer cells; opposite effect of the CDX2 homeoprotein.
    Domon-Dell C; Freund JN
    FEBS Lett; 2002 May; 518(1-3):83-7. PubMed ID: 11997022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the N-terminal activation domain of the coiled-coil coactivator in mediating transcriptional activation by beta-catenin.
    Yang CK; Kim JH; Stallcup MR
    Mol Endocrinol; 2006 Dec; 20(12):3251-62. PubMed ID: 16931570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Yin-Yang of TCF/beta-catenin signaling.
    Barker N; Morin PJ; Clevers H
    Adv Cancer Res; 2000; 77():1-24. PubMed ID: 10549354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt-1 but not epidermal growth factor induces beta-catenin/T-cell factor-dependent transcription in esophageal cancer cells.
    Mizushima T; Nakagawa H; Kamberov YG; Wilder EL; Klein PS; Rustgi AK
    Cancer Res; 2002 Jan; 62(1):277-82. PubMed ID: 11782388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transcriptional coactivator CBP interacts with beta-catenin to activate gene expression.
    Takemaru KI; Moon RT
    J Cell Biol; 2000 Apr; 149(2):249-54. PubMed ID: 10769018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ICAT inhibits beta-catenin binding to Tcf/Lef-family transcription factors and the general coactivator p300 using independent structural modules.
    Daniels DL; Weis WI
    Mol Cell; 2002 Sep; 10(3):573-84. PubMed ID: 12408825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.